Metraipolis › archive › dc_12e820b02141

Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Melanoma: A Systematic Review of Phase One Clinical Trials — Europe PMC PMID:42310990

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42310990
DOI
10.1177/15330338261452884
License (as archived)
solo-consultazione
Archived
2026-11-07T04:11:46.865Z
SHA-256 of the archived text
156bda6d0e699ba20b093e2df64227fb3b45eb3e194aa5926b94430c245ca8e1
Stable URL of this page
https://metraipolis.com/documento/dc_12e820b02141

How to cite

Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Melanoma: A Systematic Review of Phase One Clinical Trials — Europe PMC PMID:42310990 — Europe PMC (en), https://europepmc.org/article/MED/42310990 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_12e820b02141 (Metraipolis archive dc_12e820b02141, sha256 156bda6d0e699ba20b093e2df64227fb3b45eb3e194aa5926b94430c245ca8e1)
BibTeX
@misc{dc12e820b02141,
  title = {Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Melanoma: A Systematic Review of Phase One Clinical Trials — Europe PMC PMID:42310990},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42310990},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_12e820b02141; sha256 156bda6d0e699ba20b093e2df64227fb3b45eb3e194aa5926b94430c245ca8e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42310990. Agents can read the archived copy with the MCP tool read_document.